Mobius Care
Mobius Care is a precision medicine company founded by Dr. Thaddeus Stappenbeck at Cleveland Clinic, focused on transforming inflammatory bowel disease (IBD) treatment through innovative diagnostics and therapeutics. The company leverages advanced AI, multimodal patient data, and a reverse translational research model to develop AI-powered, H&E image-based predictive biomarkers that improve treatment response rates by matching patients with the most effective therapies. Mobius Care also pioneers therapeutic strategies beyond immune suppression, targeting microbial dysbiosis and promoting mucosal repair. Their solutions optimize clinical trial enrollment and drug development for biopharma partners, aiming to shift IBD care from a one-size-fits-all approach to personalized, targeted treatment that improves patient outcomes and quality of life.
Mobius Care
Mobius Care is a precision medicine company founded by Dr. Thaddeus Stappenbeck at Cleveland Clinic, focused on transforming inflammatory bowel disease (IBD) treatment through innovative diagnostics and therapeutics. The company leverages advanced AI, multimodal patient data, and a reverse translational research model to develop AI-powered, H&E image-based predictive biomarkers that improve treatment response rates by matching patients with the most effective therapies. Mobius Care also pioneers therapeutic strategies beyond immune suppression, targeting microbial dysbiosis and promoting mucosal repair. Their solutions optimize clinical trial enrollment and drug development for biopharma partners, aiming to shift IBD care from a one-size-fits-all approach to personalized, targeted treatment that improves patient outcomes and quality of life.